跳至主要内容
临床试验/NCT06797258
NCT06797258招募中不适用

Safety And Effectiveness Of FlexHD® Pliable Acellular Dermal Matrix In Implant-Based Breast Reconstruction

Musculoskeletal Transplant Foundation2 个研究点 分布在 1 个国家目标入组 259 人开始时间: 2025年3月26日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
259
试验地点
2
主要终点
Frequency of major complication

研究概览

简要总结

Prospective, multi-center, single-arm clinical study in females undergoing immediate implant-based breast reconstruction using a pre-pectoral technique

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Females at least 22 years of age
  • Scheduled to undergo unilateral or bilateral mastectomy with immediate implant-based, prepectoral breast reconstruction
  • Willing to provide Informed Consent
  • Able to return for all required study visits
  • Must read and understand English language

排除标准

  • Is of childbearing potential and has a positive pregnancy test within 7 days of study procedure
  • Has a residual gross tumor at the intended reconstruction site
  • Has undergone previous breast surgery, such as lumpectomy or breast augmentation, at the site of implantation with the exception of a biopsy
  • Has undergone previous radiation therapy to the reconstruction site or chest wall, or is scheduled to undergo post-operative radiation therapy at the reconstruction site
  • Completed chemotherapy within 3 weeks prior to surgery
  • Has been diagnosed with a comorbid condition determined by the investigator to place the subject at an increased risk of complications
  • Has a Body Mass Index (BMI) >35
  • Has used nicotine products within 1 month of screening
  • Must not have taken oral corticosteroids for a minimum of 1 month prior to the procedure or have a history of long-term use of systemic oral corticosteroids or anticipate the use during course of the study

结局指标

主要结局

Frequency of major complication

时间窗: 12 months

Complications that require additional hospitalization or reoperation

Frequency of reconstructive failure

时间窗: 12 months

Removal/explantation of the breast implant

次要结局

  • Adverse events(12 months)
  • Change in patient reported outcomes(12 months)
  • Pain(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验